Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 614

1.

Obstructive sleep apnea syndrome and arterial hypertension--a complicated relationship? The role of controlling blood pressure values in patients with OSAS.

Deleanu OC, Mălăuţ AE, Nebunoiu AM, Micheu MM, Mihălţan FD.

Pneumologia. 2014 Jan-Mar;63(1):36-43.

PMID:
24800594
2.

Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs.

Börgel J, Sanner BM, Keskin F, Bittlinsky A, Bartels NK, Büchner N, Huesing A, Rump LC, Mügge A.

Am J Hypertens. 2004 Dec;17(12 Pt 1):1081-7.

PMID:
15607612
3.

Long-term gender-specific evolution of blood pressure under CPAP therapy in hypertensive patients with obstructive sleep apnea syndrome.

Deleanu OC, Mălăuţ AE, Donoaica A, Nebunoiu AM, Mihălţan F.

Pneumologia. 2014 Oct-Dec;63(4):212-7.

PMID:
25665365
5.

Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea.

Barbé F, Durán-Cantolla J, Capote F, de la Peña M, Chiner E, Masa JF, Gonzalez M, Marín JM, Garcia-Rio F, de Atauri JD, Terán J, Mayos M, Monasterio C, del Campo F, Gomez S, de la Torre MS, Martinez M, Montserrat JM; Spanish Sleep and Breathing Group..

Am J Respir Crit Care Med. 2010 Apr 1;181(7):718-26. doi: 10.1164/rccm.200901-0050OC. Epub 2009 Dec 10.

PMID:
20007932
6.

Oral appliance versus continuous positive airway pressure in obstructive sleep apnea syndrome: a 2-year follow-up.

Doff MH, Hoekema A, Wijkstra PJ, van der Hoeven JH, Huddleston Slater JJ, de Bont LG, Stegenga B.

Sleep. 2013 Sep 1;36(9):1289-96. doi: 10.5665/sleep.2948.

7.

Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome.

Noda A, Nakata S, Koike Y, Miyata S, Kitaichi K, Nishizawa T, Nagata K, Yasuma F, Murohara T, Yokota M.

Hypertens Res. 2007 Aug;30(8):669-76.

PMID:
17917313
8.
9.

Effects of continuous positive airway pressure on blood pressure and daytime sleepiness in obstructive sleep apnea patients with coronary heart diseases under optimal medications.

Zhao Q, Liu ZH, Luo Q, Zhao ZH, Zhang HL, Wang Y.

Sleep Breath. 2012 Jun;16(2):341-7. doi: 10.1007/s11325-011-0498-9. Epub 2011 Feb 22.

PMID:
21337116
10.

[Cardiac structure and function in patients with obstructive sleep apnea syndrome and co-prevalent arterial hypertension. Influence of CPAP therapy].

Duchna HW, Myslinski W, Dichmann M, Rasche K, Schultze-Werninghaus G, Orth M.

Med Klin (Munich). 2006 Jan 15;101(1):1-8. German.

PMID:
16418808
11.

Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome.

Sugiura T, Noda A, Nakata S, Yasuda Y, Soga T, Miyata S, Nakai S, Koike Y.

Respiration. 2007;74(1):56-60. Epub 2005 Nov 18.

PMID:
16299414
12.

Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.

Litvin AY, Sukmarova ZN, Elfimova EM, Aksenova AV, Galitsin PV, Rogoza AN, Chazova IE.

Vasc Health Risk Manag. 2013;9:229-35. doi: 10.2147/VHRM.S40231. Epub 2013 May 10.

13.

Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.

Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, Gonzalez M, Lloberes P, Masa JF, De La Peña M, Carrizo S, Mayos M, Barbé F; Spanish Sleep and Breathing Group..

BMJ. 2010 Nov 24;341:c5991. doi: 10.1136/bmj.c5991.

14.

Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.

Muxfeldt ES, Margallo V, Costa LM, Guimarães G, Cavalcante AH, Azevedo JC, de Souza F, Cardoso CR, Salles GF.

Hypertension. 2015 Apr;65(4):736-42. doi: 10.1161/HYPERTENSIONAHA.114.04852. Epub 2015 Jan 19.

15.

Clinical, polysomnographic, and CPAP titration features of obstructive sleep apnea: Mixed versus purely obstructive type.

Lee SA, Lee GH, Chung YS, Kim WS.

J Neurol Sci. 2015 Aug 15;355(1-2):150-4. doi: 10.1016/j.jns.2015.06.005. Epub 2015 Jun 3.

PMID:
26066559
16.

Risk for Obstructive Sleep Apnea by Berlin Questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study.

Gus M, Gonçalves SC, Martinez D, de Abreu Silva EO, Moreira LB, Fuchs SC, Fuchs FD.

Am J Hypertens. 2008 Jul;21(7):832-5. doi: 10.1038/ajh.2008.184. Epub 2008 May 1.

PMID:
18451807
17.

Outcome of sleepiness and fatigue scores in obstructive sleep apnea syndrome patients with and without restless legs syndrome after nasal CPAP.

Rodrigues RN, Abreu e Silva Rodrigues AA, Pratesi R, Gomes MM, Vasconcelos AM, Erhardt C, Krieger J.

Arq Neuropsiquiatr. 2007 Mar;65(1):54-8.

19.

Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial.

Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, Marks GB, Cistulli PA.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):879-87. doi: 10.1164/rccm.201212-2223OC.

20.

Supplemental Content

Support Center